The CNRM Clinical Trial Pipeline shares the six stages CNRM Clinical Trials go through. It also indicates which stage each CNRM clinical trial is currently in. These stages are Planning, Protocol Development, Regulatory Review, Enrollment, Follow Up, and Analysis and Publication. The “Slidenafil for Traumatic Cerebrovascular Injury” trial has gone through all six stages and is completed. The second trial listed, named “Restoring Critical Connections with Transcranial Magnetic Stimulation,” in the enrollment stage. The third trial listed, named “Exercise and Traumatic Brain Injury” is also in the enrollment stage. The fourth trial listed, named “Transcranial Magnetic Stimulation for Depression Two Site,” has begun the enrollment stage. The fifth trial listed, named “Reconsolidation of Traumatic Memories to Resolve Post-Traumatic Stress,” has begun the enrollment stage. The sixth trial listed, named “Internet Cognitive Behavioral Therapy for TBI-related Insomnia,” is in the regulatory review stage. The seventh trial listed, named “Improving Sleep Using Bright Light Therapy” has begun the enrollment stage. The eighth trial listed, named “Transcranial Magnetic Stimulation for Depression Multisite,” is in the protocol development stage. The ninth trial listed, named “Mobile Application to Counteract Depression and Concussion,” is in the regulatory review stage. The tenth trial listed, named “Calcitonin Gene-related Peptide Antagonist for Acute Post-Traumatic Headache,” has finished the protocol development stage.